New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - sodium tetradecyl sulfate 0.2%{relative} - solution for injection - 0.2 % - active: sodium tetradecyl sulfate 0.2%{relative} excipient: benzyl alcohol dibasic sodium phosphate dodecahydrate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of minor venules and spider veins (venous flares) by injection sclerotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - sodium tetradecyl sulfate 0.5%{relative} - solution for injection - 0.5 % - active: sodium tetradecyl sulfate 0.5%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins and venous flares of the leg by injection sclerotherapy

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - sodium tetradecyl sulfate 1%{relative} - solution for injection - 1 % - active: sodium tetradecyl sulfate 1%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins of the leg by injection sclerotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - sodium tetradecyl sulfate 3%{relative} - solution for injection - 3 % - active: sodium tetradecyl sulfate 3%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins of the leg by injection sclerotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 0.5 percent weight/volume - sclerosing agents for local injection; sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 0.2 percent weight/volume - sclerosing agents for local injection; sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 1 percent weight/volume - sclerosing agents for local injection; sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 3 percent weight/volume - sclerosing agents for local injection; sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 3 percent weight/volume - sclerosing agents for local injection; sodium tetradecyl sulfate

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 5 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerothearpy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.